APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Whole Blood, Plasma and Serum Viscometers

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Whole Blood, Plasma and Serum Viscometers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17443013024 July 2026182 pages

Choose your research edition.

Industry ResearchWhole Blood, Plasma and Serum Viscometers Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Whole Blood, Plasma and Serum Viscometers Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Whole Blood, Plasma and Serum Viscometers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Whole Blood, Plasma and Serum Viscometers Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Whole Blood, Plasma and Serum Viscometers Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Whole Blood, Plasma and Serum Viscometers market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Whole Blood, Plasma and Serum Viscometers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Whole Blood, Plasma and Serum Viscometers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Whole Blood, Plasma and Serum Viscometers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Whole Blood, Plasma and Serum Viscometers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Whole Blood, Plasma and Serum Viscometers include ​BioFluid Technology, AMETEK Brookfield, Anton Paar, Benson Viscometers, Health Onvector, LAMY RHEOLOGY, LAUDA, RheoSense and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Whole Blood, Plasma and Serum Viscometers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Whole Blood, Plasma and Serum Viscometers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Whole Blood, Plasma and Serum Viscometers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Whole Blood, Plasma and Serum Viscometers market size, projected growth trends, production technologies, key applications, and end-use industries.

Whole Blood, Plasma and Serum Viscometers Segment by Company

​BioFluid Technology

AMETEK Brookfield

Anton Paar

Benson Viscometers

Health Onvector

LAMY RHEOLOGY

LAUDA

RheoSense

Thermo Fisher Scientific

Whole Blood, Plasma and Serum Viscometers Segment by Type

Rotational Viscometer

Capillary Viscometer

Whole Blood, Plasma and Serum Viscometers Segment by Application

Clinic

Hospital

Laboratory

Whole Blood, Plasma and Serum Viscometers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Blood, Plasma and Serum Viscometers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Whole Blood, Plasma and Serum Viscometers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Blood, Plasma and Serum Viscometers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Whole Blood, Plasma and Serum Viscometers market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Whole Blood, Plasma and Serum Viscometers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Whole Blood, Plasma and Serum Viscometers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Whole Blood, Plasma and Serum Viscometers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Whole Blood, Plasma and Serum Viscometers Industry Trends Table 2. Whole Blood, Plasma and Serum Viscometers Industry Drivers Table 3. Whole Blood, Plasma and Serum Viscometers Industry Opportunities and Challenges Table 4. Whole Blood, Plasma and Serum Viscometers Industry Restraints Table 5. Global Whole Blood, Plasma and Serum Viscometers Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Whole Blood, Plasma and Serum Viscometers Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Manufacturers Table 9. Global Whole Blood, Plasma and Serum Viscometers Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Whole Blood, Plasma and Serum Viscometers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Whole Blood, Plasma and Serum Viscometers Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Whole Blood, Plasma and Serum Viscometers Manufacturers, Product Type & Application Table 13. Global Whole Blood, Plasma and Serum Viscometers Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Whole Blood, Plasma and Serum Viscometers by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rotational Viscometer Table 17. Major Manufacturers of Capillary Viscometer Table 18. Global Whole Blood, Plasma and Serum Viscometers Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Whole Blood, Plasma and Serum Viscometers Sales by Type (2021-2026) & (k units) Table 20. Global Whole Blood, Plasma and Serum Viscometers Sales by Type (2027-2032) & (k units) Table 21. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Type (2021-2026) Table 22. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Type (2027-2032) Table 23. Global Whole Blood, Plasma and Serum Viscometers Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Whole Blood, Plasma and Serum Viscometers Revenue by Type (2021-2026) & (k units) Table 25. Global Whole Blood, Plasma and Serum Viscometers Revenue by Type (2027-2032) & (k units) Table 26. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Type (2021-2026) Table 27. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Laboratory Table 31. Global Whole Blood, Plasma and Serum Viscometers Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Whole Blood, Plasma and Serum Viscometers Sales by Application (2021-2026) & (k units) Table 33. Global Whole Blood, Plasma and Serum Viscometers Sales by Application (2027-2032) & (k units) Table 34. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Application (2021-2026) Table 35. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Application (2027-2032) Table 36. Global Whole Blood, Plasma and Serum Viscometers Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Whole Blood, Plasma and Serum Viscometers Revenue by Application (2021-2026) & (k units) Table 38. Global Whole Blood, Plasma and Serum Viscometers Revenue by Application (2027-2032) & (k units) Table 39. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Application (2021-2026) Table 40. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Application (2027-2032) Table 41. Global Whole Blood, Plasma and Serum Viscometers Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Whole Blood, Plasma and Serum Viscometers Sales by Region (2021-2026) & (k units) Table 43. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Region (2021-2026) Table 44. Global Whole Blood, Plasma and Serum Viscometers Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Whole Blood, Plasma and Serum Viscometers Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Whole Blood, Plasma and Serum Viscometers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2026) & (k units) Table 48. North America Whole Blood, Plasma and Serum Viscometers Sales by Country (2027-2032) & (k units) Table 49. Europe Whole Blood, Plasma and Serum Viscometers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2026) & (k units) Table 51. Europe Whole Blood, Plasma and Serum Viscometers Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Whole Blood, Plasma and Serum Viscometers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Whole Blood, Plasma and Serum Viscometers Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Sales by Country (2027-2032) & (k units) Table 58. Global Whole Blood, Plasma and Serum Viscometers Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Whole Blood, Plasma and Serum Viscometers Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Whole Blood, Plasma and Serum Viscometers Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Region (2021-2026) Table 62. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Region (2027-2032) Table 63. ​BioFluid Technology Company Information Table 64. ​BioFluid Technology Business Overview Table 65. ​BioFluid Technology Whole Blood, Plasma and Serum Viscometers Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ​BioFluid Technology Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 67. ​BioFluid Technology Recent Development Table 68. AMETEK Brookfield Company Information Table 69. AMETEK Brookfield Business Overview Table 70. AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 72. AMETEK Brookfield Recent Development Table 73. Anton Paar Company Information Table 74. Anton Paar Business Overview Table 75. Anton Paar Whole Blood, Plasma and Serum Viscometers Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Anton Paar Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 77. Anton Paar Recent Development Table 78. Benson Viscometers Company Information Table 79. Benson Viscometers Business Overview Table 80. Benson Viscometers Whole Blood, Plasma and Serum Viscometers Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Benson Viscometers Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 82. Benson Viscometers Recent Development Table 83. Health Onvector Company Information Table 84. Health Onvector Business Overview Table 85. Health Onvector Whole Blood, Plasma and Serum Viscometers Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Health Onvector Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 87. Health Onvector Recent Development Table 88. LAMY RHEOLOGY Company Information Table 89. LAMY RHEOLOGY Business Overview Table 90. LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 92. LAMY RHEOLOGY Recent Development Table 93. LAUDA Company Information Table 94. LAUDA Business Overview Table 95. LAUDA Whole Blood, Plasma and Serum Viscometers Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. LAUDA Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 97. LAUDA Recent Development Table 98. RheoSense Company Information Table 99. RheoSense Business Overview Table 100. RheoSense Whole Blood, Plasma and Serum Viscometers Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. RheoSense Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 102. RheoSense Recent Development Table 103. Thermo Fisher Scientific Company Information Table 104. Thermo Fisher Scientific Business Overview Table 105. Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Product Portfolio Table 107. Thermo Fisher Scientific Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Whole Blood, Plasma and Serum Viscometers Distributors List Table 111. Whole Blood, Plasma and Serum Viscometers Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Whole Blood, Plasma and Serum Viscometers Product Image Figure 2. Global Whole Blood, Plasma and Serum Viscometers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Whole Blood, Plasma and Serum Viscometers Market Size (2021-2032) & (US$ Million) Figure 4. Global Whole Blood, Plasma and Serum Viscometers Sales (2021-2032) & (k units) Figure 5. Global Whole Blood, Plasma and Serum Viscometers Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Whole Blood, Plasma and Serum Viscometers Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rotational Viscometer Image Figure 9. Capillary Viscometer Image Figure 10. Global Whole Blood, Plasma and Serum Viscometers Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Type (2021-2032) Figure 13. Global Whole Blood, Plasma and Serum Viscometers Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Type (2021-2032) Figure 16. Clinic Image Figure 17. Hospital Image Figure 18. Laboratory Image Figure 19. Global Whole Blood, Plasma and Serum Viscometers Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Application (2021-2032) Figure 22. Global Whole Blood, Plasma and Serum Viscometers Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Application (2021-2032) Figure 25. North America Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Whole Blood, Plasma and Serum Viscometers Sales Market Share by Country (2021-2032) Figure 27. U.S. Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Whole Blood, Plasma and Serum Viscometers Sales Market Share by Country (2021-2032) Figure 32. Germany Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Whole Blood, Plasma and Serum Viscometers Sales Market Share by Country (2021-2032) Figure 39. China Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Sales Market Share by Country (2021-2032) Figure 47. Brazil Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Whole Blood, Plasma and Serum Viscometers Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Whole Blood, Plasma and Serum Viscometers Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Whole Blood, Plasma and Serum Viscometers Revenue (2021-2032) & (US$ Million) Figure 58. North America Whole Blood, Plasma and Serum Viscometers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Whole Blood, Plasma and Serum Viscometers Revenue (2021-2032) & (US$ Million) Figure 60. Europe Whole Blood, Plasma and Serum Viscometers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Whole Blood, Plasma and Serum Viscometers Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Whole Blood, Plasma and Serum Viscometers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Whole Blood, Plasma and Serum Viscometers Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Whole Blood, Plasma and Serum Viscometers Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Rotational Viscometer
  • Capillary Viscometer
Applications
  • Clinic
  • Hospital
  • Laboratory
Companies covered
  • ​BioFluid Technology
  • AMETEK Brookfield
  • Anton Paar
  • Benson Viscometers
  • Health Onvector
  • LAMY RHEOLOGY
  • LAUDA
  • RheoSense
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Whole Blood, Plasma and Serum Viscometers Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Whole Blood, Plasma and Serum Viscometers Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Whole Blood, Plasma and Serum Viscometers Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Whole Blood, Plasma and Serum Viscometers Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Whole Blood, Plasma and Serum Viscometers Market Dynamics
  1. 2.1 Whole Blood, Plasma and Serum Viscometers Industry Trends
  2. 2.2 Whole Blood, Plasma and Serum Viscometers Industry Drivers
  3. 2.3 Whole Blood, Plasma and Serum Viscometers Industry Opportunities and Challenges
  4. 2.4 Whole Blood, Plasma and Serum Viscometers Industry Restraints
3 Whole Blood, Plasma and Serum Viscometers Market by Manufacturers
  1. 3.1 Global Whole Blood, Plasma and Serum Viscometers Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Manufacturers (2021-2026)
  3. 3.3 Global Whole Blood, Plasma and Serum Viscometers Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Whole Blood, Plasma and Serum Viscometers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Whole Blood, Plasma and Serum Viscometers Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Whole Blood, Plasma and Serum Viscometers Manufacturers, Product Type & Application
  7. 3.7 Global Whole Blood, Plasma and Serum Viscometers Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Whole Blood, Plasma and Serum Viscometers Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Whole Blood, Plasma and Serum Viscometers Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Whole Blood, Plasma and Serum Viscometers Tier 1, Tier 2, and Tier 3
4 Whole Blood, Plasma and Serum Viscometers Market by Type
  1. 4.1 Whole Blood, Plasma and Serum Viscometers Type Introduction
  2. 4.1.1 Rotational Viscometer
  3. 4.1.2 Capillary Viscometer
  4. 4.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Type
  5. 4.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Type (2021-2032)
  7. 4.2.3 Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Type (2021-2032)
  8. 4.3 Global Whole Blood, Plasma and Serum Viscometers Revenue by Type
  9. 4.3.1 Global Whole Blood, Plasma and Serum Viscometers Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Whole Blood, Plasma and Serum Viscometers Revenue by Type (2021-2032)
  11. 4.3.3 Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Type (2021-2032)
5 Whole Blood, Plasma and Serum Viscometers Market by Application
  1. 5.1 Whole Blood, Plasma and Serum Viscometers Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Laboratory
  5. 5.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Application
  6. 5.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Application (2021-2032)
  8. 5.2.3 Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Application (2021-2032)
  9. 5.3 Global Whole Blood, Plasma and Serum Viscometers Revenue by Application
  10. 5.3.1 Global Whole Blood, Plasma and Serum Viscometers Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Whole Blood, Plasma and Serum Viscometers Revenue by Application (2021-2032)
  12. 5.3.3 Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Application (2021-2032)
6 Global Whole Blood, Plasma and Serum Viscometers Sales by Region
  1. 6.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Region (2021-2032)
  3. 6.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Region (2021-2026)
  4. 6.2.2 Global Whole Blood, Plasma and Serum Viscometers Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Whole Blood, Plasma and Serum Viscometers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Whole Blood, Plasma and Serum Viscometers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Whole Blood, Plasma and Serum Viscometers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Whole Blood, Plasma and Serum Viscometers Revenue by Region
  1. 7.1 Global Whole Blood, Plasma and Serum Viscometers Revenue by Region
  2. 7.1.1 Global Whole Blood, Plasma and Serum Viscometers Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Whole Blood, Plasma and Serum Viscometers Revenue by Region (2021-2026)
  4. 7.1.3 Global Whole Blood, Plasma and Serum Viscometers Revenue by Region (2027-2032)
  5. 7.1.4 Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Whole Blood, Plasma and Serum Viscometers Revenue (2021-2032)
  8. 7.2.2 North America Whole Blood, Plasma and Serum Viscometers Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Whole Blood, Plasma and Serum Viscometers Revenue (2021-2032)
  11. 7.3.2 Europe Whole Blood, Plasma and Serum Viscometers Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Whole Blood, Plasma and Serum Viscometers Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Whole Blood, Plasma and Serum Viscometers Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Whole Blood, Plasma and Serum Viscometers Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ​BioFluid Technology
  2. 8.1.1 ​BioFluid Technology Company Information
  3. 8.1.2 ​BioFluid Technology Business Overview
  4. 8.1.3 ​BioFluid Technology Whole Blood, Plasma and Serum Viscometers Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ​BioFluid Technology Whole Blood, Plasma and Serum Viscometers Product Portfolio
  6. 8.1.5 ​BioFluid Technology Recent Developments
  7. 8.2 AMETEK Brookfield
  8. 8.2.1 AMETEK Brookfield Company Information
  9. 8.2.2 AMETEK Brookfield Business Overview
  10. 8.2.3 AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Product Portfolio
  12. 8.2.5 AMETEK Brookfield Recent Developments
  13. 8.3 Anton Paar
  14. 8.3.1 Anton Paar Company Information
  15. 8.3.2 Anton Paar Business Overview
  16. 8.3.3 Anton Paar Whole Blood, Plasma and Serum Viscometers Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Anton Paar Whole Blood, Plasma and Serum Viscometers Product Portfolio
  18. 8.3.5 Anton Paar Recent Developments
  19. 8.4 Benson Viscometers
  20. 8.4.1 Benson Viscometers Company Information
  21. 8.4.2 Benson Viscometers Business Overview
  22. 8.4.3 Benson Viscometers Whole Blood, Plasma and Serum Viscometers Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Benson Viscometers Whole Blood, Plasma and Serum Viscometers Product Portfolio
  24. 8.4.5 Benson Viscometers Recent Developments
  25. 8.5 Health Onvector
  26. 8.5.1 Health Onvector Company Information
  27. 8.5.2 Health Onvector Business Overview
  28. 8.5.3 Health Onvector Whole Blood, Plasma and Serum Viscometers Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Health Onvector Whole Blood, Plasma and Serum Viscometers Product Portfolio
  30. 8.5.5 Health Onvector Recent Developments
  31. 8.6 LAMY RHEOLOGY
  32. 8.6.1 LAMY RHEOLOGY Company Information
  33. 8.6.2 LAMY RHEOLOGY Business Overview
  34. 8.6.3 LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Product Portfolio
  36. 8.6.5 LAMY RHEOLOGY Recent Developments
  37. 8.7 LAUDA
  38. 8.7.1 LAUDA Company Information
  39. 8.7.2 LAUDA Business Overview
  40. 8.7.3 LAUDA Whole Blood, Plasma and Serum Viscometers Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LAUDA Whole Blood, Plasma and Serum Viscometers Product Portfolio
  42. 8.7.5 LAUDA Recent Developments
  43. 8.8 RheoSense
  44. 8.8.1 RheoSense Company Information
  45. 8.8.2 RheoSense Business Overview
  46. 8.8.3 RheoSense Whole Blood, Plasma and Serum Viscometers Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RheoSense Whole Blood, Plasma and Serum Viscometers Product Portfolio
  48. 8.8.5 RheoSense Recent Developments
  49. 8.9 Thermo Fisher Scientific
  50. 8.9.1 Thermo Fisher Scientific Company Information
  51. 8.9.2 Thermo Fisher Scientific Business Overview
  52. 8.9.3 Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Product Portfolio
  54. 8.9.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Whole Blood, Plasma and Serum Viscometers Value Chain Analysis
  2. 9.1.1 Whole Blood, Plasma and Serum Viscometers Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Whole Blood, Plasma and Serum Viscometers Production Mode & Process
  6. 9.2 Whole Blood, Plasma and Serum Viscometers Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Whole Blood, Plasma and Serum Viscometers Distributors
  9. 9.2.3 Whole Blood, Plasma and Serum Viscometers Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst